Alpha Tau Medical Ltd
DRTS5.080USD
-0.020-0.39%
收盤 12/23, 16:00（美東）報價延遲15分鐘
433.14M總市值
虧損本益比TTM
關於 Alpha Tau Medical Ltd 公司
Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.
Alpha Tau Medical Ltd簡介
公司代碼DRTS
公司名稱Alpha Tau Medical Ltd
上市日期Mar 08, 2022
CEOSofer (Uzi)
員工數量125
證券類型Ordinary Share
年結日Mar 08
公司地址Kiryat Hamada 5
城市JERUSALEM
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Israel
郵編9777605
電話97235774115
網址https://www.alphatau.com/
公司代碼DRTS
上市日期Mar 08, 2022
CEOSofer (Uzi)
Alpha Tau Medical Ltd公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Uzi Sofer
Mr. Uzi Sofer
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
11.52M
--
Mr. Michael Avruch
Mr. Michael Avruch
Independent Director
Independent Director
1.55M
+0.17%
Prof. Yona Keisari
Prof. Yona Keisari
Chief Scientific Officer
Chief Scientific Officer
504.27K
+0.16%
Mr. Amnon Gat
Mr. Amnon Gat
Chief Operations Officer
Chief Operations Officer
68.47K
--
Mr. Raphi Levy
Mr. Raphi Levy
Chief Financial Officer
Chief Financial Officer
--
--
Prof. Itzhak Kelson
Prof. Itzhak Kelson
Chief Physics Officer
Chief Physics Officer
--
--
Dr. Robert Den, M.D.
Dr. Robert Den, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Gary Leibler
Mr. Gary Leibler
Independent Director
Independent Director
--
--
Mr. Alan Adler
Mr. Alan Adler
Independent Director
Independent Director
--
--
Dr. S. Morry Blumenfeld, Ph.D.
Dr. S. Morry Blumenfeld, Ph.D.
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Uzi Sofer
Mr. Uzi Sofer
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
11.52M
--
Mr. Michael Avruch
Mr. Michael Avruch
Independent Director
Independent Director
1.55M
+0.17%
Prof. Yona Keisari
Prof. Yona Keisari
Chief Scientific Officer
Chief Scientific Officer
504.27K
+0.16%
Mr. Amnon Gat
Mr. Amnon Gat
Chief Operations Officer
Chief Operations Officer
68.47K
--
Mr. Raphi Levy
Mr. Raphi Levy
Chief Financial Officer
Chief Financial Officer
--
--
Prof. Itzhak Kelson
Prof. Itzhak Kelson
Chief Physics Officer
Chief Physics Officer
--
--
收入明細
由於公司未披露，未能獲取相關數據
由於公司未披露，未能獲取相關數據
業務
地區
由於公司未披露，未能獲取相關數據
股東統計
更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
Oramed Pharmaceuticals Inc
16.55%
Sofer (Uzi)
13.51%
Avruch (Michael)
1.82%
Hightower Advisors, LLC
0.81%
Keisari (Yona)
0.59%
其他
66.73%
持股股東
持股股東
佔比
Oramed Pharmaceuticals Inc
16.55%
Sofer (Uzi)
13.51%
Avruch (Michael)
1.82%
Hightower Advisors, LLC
0.81%
Keisari (Yona)
0.59%
其他
66.73%
股東類型
持股股東
佔比
Corporation
16.55%
Individual Investor
16.16%
Investment Advisor
1.67%
Investment Advisor/Hedge Fund
0.57%
Hedge Fund
0.19%
Research Firm
0.05%
Bank and Trust
0.03%
Venture Capital
0.01%
其他
64.77%
機構持股
更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
47
2.15M
2.50%
--
2025Q3
54
2.18M
2.66%
+245.80K
2025Q2
48
1.93M
2.17%
+414.57K
2025Q1
48
1.52M
2.85%
-495.42K
2024Q4
46
1.33M
2.80%
+27.93K
2024Q3
50
1.30M
4.99%
-29.19K
2024Q2
53
1.33M
5.76%
-530.87K
2024Q1
56
1.86M
5.76%
-2.16M
2023Q4
128
1.91M
37.70%
+832.42K
2023Q3
130
1.04M
38.54%
+25.86K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Oramed Pharmaceuticals Inc
14.11M
16.59%
+14.11M
--
Apr 24, 2025
Sofer (Uzi)
11.52M
13.54%
--
--
Jun 30, 2025
Avruch (Michael)
1.55M
1.82%
+2.71K
+0.17%
Mar 01, 2025
Hightower Advisors, LLC
686.55K
0.81%
+455.85K
+197.59%
Jun 30, 2025
Keisari (Yona)
504.27K
0.59%
+781.00
+0.16%
Mar 01, 2025
HoyleCohen, LLC
269.09K
0.32%
--
--
Jun 30, 2024
Levin Capital Strategies, L.P.
192.51K
0.23%
-30.00K
-13.48%
Jun 30, 2025
Kovitz Investment Group Partners, LLC
204.83K
0.24%
-21.49K
-9.49%
Jun 30, 2025
Mariner Wealth Advisors
43.12K
0.05%
+3.00K
+7.48%
Jun 30, 2025
Milch (David Mark)
88.74K
0.1%
-2.00K
-2.20%
Mar 01, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
常見問題
Alpha Tau Medical Ltd的前五大股東是誰？
Alpha Tau Medical Ltd的前五大股東如下：
Oramed Pharmaceuticals Inc持有股份：14.11M佔總股份比例：16.59%。
Sofer (Uzi)持有股份：11.52M佔總股份比例：13.54%。
Avruch (Michael)持有股份：1.55M佔總股份比例：1.82%。
Hightower Advisors, LLC持有股份：686.55K佔總股份比例：0.81%。
Keisari (Yona)持有股份：504.27K佔總股份比例：0.59%。
Oramed Pharmaceuticals Inc持有股份：14.11M佔總股份比例：16.59%。
Sofer (Uzi)持有股份：11.52M佔總股份比例：13.54%。
Avruch (Michael)持有股份：1.55M佔總股份比例：1.82%。
Hightower Advisors, LLC持有股份：686.55K佔總股份比例：0.81%。
Keisari (Yona)持有股份：504.27K佔總股份比例：0.59%。
Alpha Tau Medical Ltd的前三大股東類型是什麼？
Alpha Tau Medical Ltd 的前三大股東類型分別是：
Oramed Pharmaceuticals Inc
Sofer (Uzi)
Avruch (Michael)
Oramed Pharmaceuticals Inc
Sofer (Uzi)
Avruch (Michael)
有多少機構持有Alpha Tau Medical Ltd(DRTS)的股份？
截至2025Q4，共有47家機構持有Alpha Tau Medical Ltd的股份，合計持有的股份價值約為2.15M，占公司總股份的2.50% 。與2025Q3相比，機構持股有所增加，增幅為-0.17%。
哪個業務部門對Alpha Tau Medical Ltd的收入貢獻最大？
在--，--業務部門對Alpha Tau Medical Ltd的收入貢獻最大，創收--，占總收入的--% 。
